<?xml version="1.0" encoding="UTF-8"?>
<p>Despite the attention and research interest sepsis has received, FDA-approved drugs to treat sepsis are still lacking. The current guideline for the treatment of sepsis is centered loosely on the Surviving Sepsis Campaign. The campaign was launched in 2004 [
 <xref rid="B24" ref-type="bibr">24</xref>] and updated every four years [
 <xref rid="B2" ref-type="bibr">2</xref>, 
 <xref rid="B25" ref-type="bibr">25</xref>, 
 <xref rid="B26" ref-type="bibr">26</xref>], including a revised bundle developed as an update to the 2016 edition [
 <xref rid="B27" ref-type="bibr">27</xref>]. The campaign defined numerous treatment procedures and methods to deal with sepsis patients, which mainly emphasize initial resuscitation, early diagnosis, and antimicrobial therapy [
 <xref rid="B2" ref-type="bibr">2</xref>].
</p>
